Literature DB >> 14610471

Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness.

Mika J Mäkelä1, Ralph Tripp, Azzeddine Dakhama, Jun-Won Park, Toshihide Ikemura, Anthony Joetham, Matti Waris, Larry J Anderson, Erwin W Gelfand.   

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) bronchiolitis in early life can lead to changes in airway function, but there are likely additional predisposing factors, such as prior allergen exposure, determining which children develop wheezing and asthma.
OBJECTIVE: To define the effects of prior airway exposure to sensitizing allergen on the development of airway inflammation and hyperresponsiveness (AHR) to subsequent RSV infection.
METHODS: BALB/c mice were exposed to ovalbumin or PBS exclusively through the airways and subsequently infected with RSV or sham-inoculated. AHR, lung inflammation, and the frequency of cytokine-producing T lymphocytes in the lung were determined.
RESULTS: In PBS-exposed mice, RSV infection induced AHR and an increased proportion of TH1-type (IFN-gamma and IL-12) cytokine-producing cells in the lungs. However, in mice previously exposed to ovalbumin through the airways and subsequently infected with RSV, the degree of AHR was significantly increased and was associated with an increased proportion of TH2 (IL-4, IL-5) cytokine-producing T lymphocytes. This response was also associated with an increased accumulation of eosinophils, neutrophils, and CD8+ T cells in the lungs.
CONCLUSIONS: These data suggest that prior airway exposure to allergen may predispose sensitized hosts to a greater degree of altered airway function upon subsequent respiratory viral infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14610471     DOI: 10.1016/s0091-6749(03)02020-7

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

Review 1.  Pathogenesis of respiratory syncytial virus infection in the murine model.

Authors:  R Stokes Peebles; Barney S Graham
Journal:  Proc Am Thorac Soc       Date:  2005

Review 2.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

3.  Neonatal respiratory syncytial virus infection has an effect on lung inflammation and the CD4(+) CD25(+) T cell subpopulation during ovalbumin sensitization in adult mice.

Authors:  A Comas-García; C P López-Pacheco; E A García-Zepeda; G Soldevila; P Ramos-Martínez; J Ramos-Castañeda
Journal:  Clin Exp Immunol       Date:  2016-05-12       Impact factor: 4.330

Review 4.  Development of asthma is determined by the age-dependent host response to respiratory virus infection: therapeutic implications.

Authors:  Erwin W Gelfand
Journal:  Curr Opin Immunol       Date:  2012-09-13       Impact factor: 7.486

Review 5.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

6.  The Role of RSV Infection in Asthma Initiation and Progression: Findings in a Mouse Model.

Authors:  Junyan Han; Katsuyuki Takeda; Erwin W Gelfand
Journal:  Pulm Med       Date:  2011-07-02

7.  IL-4 increases type 2, but not type 1, cytokine production in CD8+ T cells from mild atopic asthmatics.

Authors:  Luminita A Stanciu; Kevan Roberts; Nikolaos G Papadopoulos; Sang-Heon Cho; Stephen T Holgate; Anthony J Coyle; Sebastian L Johnston
Journal:  Respir Res       Date:  2005-07-07

Review 8.  Respiratory viruses and eosinophils: exploring the connections.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Joseph B Domachowske
Journal:  Antiviral Res       Date:  2009-04-16       Impact factor: 5.970

9.  Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization.

Authors:  S Tourdot; S Mathie; T Hussell; L Edwards; H Wang; P J M Openshaw; J Schwarze; C M Lloyd
Journal:  Clin Exp Allergy       Date:  2008-06       Impact factor: 5.018

10.  Need for a safe vaccine against respiratory syncytial virus infection.

Authors:  Joo-Young Kim; Jun Chang
Journal:  Korean J Pediatr       Date:  2012-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.